協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/01/19 | 2,880 | 2,881 | 2,853 | 2,857 | -49 | -1.7% | 923,200 |
| 2023/01/18 | 2,859 | 2,921 | 2,855 | 2,906 | +67 | +2.4% | 1,106,400 |
| 2023/01/17 | 2,849 | 2,852 | 2,824 | 2,839 | +1 | ±0% | 639,900 |
| 2023/01/16 | 2,850 | 2,861 | 2,831 | 2,838 | -43 | -1.5% | 865,600 |
| 2023/01/13 | 2,890 | 2,934 | 2,859 | 2,881 | -39 | -1.3% | 998,800 |
| 2023/01/12 | 2,943 | 2,953 | 2,881 | 2,920 | -21 | -0.7% | 775,100 |
| 2023/01/11 | 2,899 | 2,962 | 2,887 | 2,941 | +66 | +2.3% | 1,155,600 |
| 2023/01/10 | 2,891 | 2,920 | 2,875 | 2,875 | -38 | -1.3% | 789,000 |
| 2023/01/06 | 2,911 | 2,930 | 2,898 | 2,913 | -3 | -0.1% | 862,100 |
| 2023/01/05 | 2,979 | 2,990 | 2,887 | 2,916 | -54 | -1.8% | 909,400 |
| 2023/01/04 | 2,981 | 2,989 | 2,945 | 2,970 | -50 | -1.7% | 833,100 |
| 2022/12/30 | 3,060 | 3,060 | 3,010 | 3,020 | -15 | -0.5% | 569,500 |
| 2022/12/29 | 2,986 | 3,035 | 2,973 | 3,035 | -10 | -0.3% | 819,600 |
| 2022/12/28 | 3,000 | 3,055 | 2,992 | 3,045 | +35 | +1.2% | 576,100 |
| 2022/12/27 | 3,065 | 3,075 | 3,010 | 3,010 | -25 | -0.8% | 326,200 |
| 2022/12/26 | 3,030 | 3,040 | 3,015 | 3,035 | +5 | +0.2% | 241,800 |
| 2022/12/23 | 3,025 | 3,045 | 3,010 | 3,030 | -5 | -0.2% | 433,900 |
| 2022/12/22 | 3,040 | 3,055 | 3,010 | 3,035 | +15 | +0.5% | 721,600 |
| 2022/12/21 | 3,020 | 3,040 | 3,005 | 3,020 | -20 | -0.7% | 822,900 |
| 2022/12/20 | 3,100 | 3,100 | 3,000 | 3,040 | -35 | -1.1% | 698,800 |
| 2022/12/19 | 3,075 | 3,085 | 3,040 | 3,075 | -30 | -1% | 576,900 |
| 2022/12/16 | 3,060 | 3,115 | 3,050 | 3,105 | +5 | +0.2% | 906,700 |
| 2022/12/15 | 3,145 | 3,145 | 3,100 | 3,100 | -50 | -1.6% | 461,300 |
| 2022/12/14 | 3,110 | 3,155 | 3,100 | 3,150 | +50 | +1.6% | 533,200 |
| 2022/12/13 | 3,100 | 3,115 | 3,085 | 3,100 | +20 | +0.6% | 414,100 |
| 2022/12/12 | 3,050 | 3,085 | 3,045 | 3,080 | -5 | -0.2% | 497,500 |
| 2022/12/09 | 3,020 | 3,110 | 3,020 | 3,085 | +15 | +0.5% | 1,157,400 |
| 2022/12/08 | 3,070 | 3,095 | 3,050 | 3,070 | -5 | -0.2% | 683,400 |
| 2022/12/07 | 3,070 | 3,085 | 3,040 | 3,075 | -20 | -0.6% | 1,024,100 |
| 2022/12/06 | 3,130 | 3,160 | 3,090 | 3,095 | -75 | -2.4% | 923,300 |
| 2022/12/05 | 3,145 | 3,190 | 3,110 | 3,170 | +50 | +1.6% | 832,900 |
| 2022/12/02 | 3,170 | 3,180 | 3,105 | 3,120 | -90 | -2.8% | 956,200 |
| 2022/12/01 | 3,230 | 3,230 | 3,195 | 3,210 | +35 | +1.1% | 873,200 |
| 2022/11/30 | 3,175 | 3,185 | 3,130 | 3,175 | -20 | -0.6% | 3,177,000 |
| 2022/11/29 | 3,255 | 3,265 | 3,190 | 3,195 | -55 | -1.7% | 983,600 |
| 2022/11/28 | 3,270 | 3,285 | 3,250 | 3,250 | -5 | -0.2% | 784,200 |
| 2022/11/25 | 3,320 | 3,320 | 3,250 | 3,255 | -45 | -1.4% | 671,400 |
| 2022/11/24 | 3,350 | 3,380 | 3,290 | 3,300 | -15 | -0.5% | 775,700 |
| 2022/11/22 | 3,290 | 3,335 | 3,280 | 3,315 | +45 | +1.4% | 817,600 |
| 2022/11/21 | 3,305 | 3,310 | 3,255 | 3,270 | +5 | +0.2% | 936,400 |
| 2022/11/18 | 3,175 | 3,275 | 3,170 | 3,265 | +100 | +3.2% | 1,031,000 |
| 2022/11/17 | 3,140 | 3,175 | 3,135 | 3,165 | +55 | +1.8% | 742,000 |
| 2022/11/16 | 3,115 | 3,125 | 3,060 | 3,110 | -40 | -1.3% | 844,500 |
| 2022/11/15 | 3,160 | 3,185 | 3,135 | 3,150 | -10 | -0.3% | 771,500 |
| 2022/11/14 | 3,195 | 3,205 | 3,145 | 3,160 | -5 | -0.2% | 835,000 |
| 2022/11/11 | 3,180 | 3,180 | 3,130 | 3,165 | +35 | +1.1% | 1,572,100 |
| 2022/11/10 | 3,085 | 3,145 | 3,075 | 3,130 | +30 | +1% | 1,183,600 |
| 2022/11/09 | 3,205 | 3,225 | 3,050 | 3,100 | -150 | -4.6% | 2,275,000 |
| 2022/11/08 | 3,235 | 3,280 | 3,190 | 3,250 | +30 | +0.9% | 1,413,100 |
| 2022/11/07 | 3,250 | 3,290 | 3,185 | 3,220 | -155 | -4.6% | 1,897,700 |
601～
650
件表示中 / 3732件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 247,000円 | -3.5% | -11.3% | 2.43% | 22.68倍 | 1.54倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 138,900円 | +0.9% | +380.2% | 5.62% | 19.13倍 | 1.68倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 254,600円 | +20.9% | +10.6% | 2.59% | 12.03倍 | 1.62倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 404,200円 | +0.1% | -3.4% | 3.96% | 27.48倍 | 1.38倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 155,200円 | +0.6% | +43.3% | 5.15% | 10.88倍 | 0.95倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
